A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.
This study has been completed.
Information provided by:
First received: December 18, 2007
Last updated: March 25, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||November 2009|
|Estimated Primary Completion Date:||No date given|